Maxcyte inc ipo
WebToday's IPO for cell-engineering company MaxCyte, Inc. (NASDAQ: MXCT) opened for trading at $16.99 after pricing 13,500,000 shares of common stock at an initial offering price of US$13.00 per ... Web26 jul. 2024 · MaxCyte, Inc. (NASDAQ: MXCT) today announced the commencement of an underwritten offering of 12,000,000 shares of common stock (the "Offering") at an expected offering price between $11.50...
Maxcyte inc ipo
Did you know?
Web30 jul. 2024 · MaxCyte, Inc., (NASDAQ: MXCT ), a leading provider of cell-engineering platform technologies, today announced the pricing of its upsized offering of 13,500,000 … WebUK establishments for MAXCYTE, INC. (FC033088) More for MAXCYTE, INC. (FC033088) Overseas company address 22 Firstfield Road, Suite 110, Gaithersburg, Md, United …
WebFor the biopharma industry investment, business development and competitive intelligence professionals who require information to support financing, partnering and licensing … Web8 apr. 2024 · MaxCyte, Inc. ( NASDAQ:MXCT - Get Rating) EVP Thomas M. Ross sold 6,967 shares of the stock in a transaction on Wednesday, April 5th. The shares were …
Web6 apr. 2024 · MaxCyte Inc (MXCT) has a Smart Score of N/A based on an analysis of 8 unique data sets, ... Calendars Earnings Calendar Dividend Calendar IPO Calendar Stock Market Holidays. Education Glossary TipRanks Labs. Plans Plans & Pricing API for Institutions. Company About TipRanks Careers Contact Us Reviews. Web30 jul. 2024 · GAITHERSBURG, Md., July 29, 2024 /PRNewswire/ -- MaxCyte, Inc., (LSE: MXCT, MXCN), a leading provider of cell-engineering platform technologies, today …
Web2 aug. 2024 · -- MaxCyte said Monday the underwriters for its initial public offering exercised the overallotment option in full, increasing the total proceeds to about $201.8 million. The …
Web26 jul. 2024 · MaxCyte Inc. released details Monday for a planned U.S. IPO that will make the biotech dual-listed in New York and London while valuing the firm at up to $1.3B.The … lawry\\u0027s in beverly hills caWebMAXCYTE, INC. : Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) GlobeNewswire 1 week ago MaxCyte … lawry\u0027s house of prime rib las vegasWebHe was a founder of MaxCyte in July 1998. Previously, he was President, CEO and a Director of Immunicon Corporation. He also held various executive positions with Life Technologies, Inc. ... where he was instrumental in the company’s $288 million IPO. He previously served as CFO and Strategy Officer at Neon Therapeutics ... lawry\\u0027s ishpemingWeb9 jul. 2024 · MaxCyte, which provides cell engineering devices and services, filed on Friday with the SEC to raise up to $100 million in an initial public offering. The company is currently listed on London's... lawry\\u0027s ingredientsWebFunding. MaxCyte has raised a total of $30.5M in funding over 8 rounds. Their latest funding was raised on Dec 16, 2014 from a Venture - Series Unknown round. MaxCyte is … lawry\u0027s in chicago closingWeb8 apr. 2024 · MaxCyte, Inc. ( NASDAQ:MXCT - Get Rating) EVP Thomas M. Ross sold 6,967 shares of the stock in a transaction on Wednesday, April 5th. The shares were sold at an average price of $5.00, for a total value of $34,835.00. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Thomas M. Ross also … karl anthony towns stranger things shoesWeb12 apr. 2024 · MaxCyte's mailing address is 22 Firstfield Rd Ste 110, GAITHERSBURG, MD 20878-1795, United States. The official website for the company is www.maxcyte.com. … karl anthony towns stats career